HLA-B*44 allele associated with clinical parameters in HIV-1 infected Moroccan cohort
Keywords:HLA-B*44 allele, HIV infection, Morocco
Background: The human leukocyte antigen-B*44 (HLA-B*44) allele has been reported to have promising results in the control of human immunodeficiency virus-1 (HIV-1) infection and associated with protection against HIV-1 disease progression. In the Moroccan HIV-1 infected patients, the contribution of this allele has not been established. This study aimed to evaluate the distribution of HLA-B*44 allele among HIV-1-infected in Morocco. Additionally, investigate HLA-B*44 allele association with demographical and HIV clinical parameters.
Methods: One hundred and sixty-seven HIV-1 infected, antiretroviral naive individuals were enrolled in this study. The HLA-B*44 allele screening was performed using the PCR amplification.
Results: Of the 167 individuals genotyped, 26 (16%) of them expressing the HLA-B*44 allele. Clinical stages at diagnosis, median pre-treatment HIV viral load (pVL) and CD4 T cell counts differ significantly (p = 0.0001, p=0.001 and p=0.0001 respectively) between the patients who had been expressing the HLA-B*44 allele and patients who had not been expressing this allele. The presence of HLA-B*44 allele was significantly associated with pVL and CD4 T cell counts (p=0.004 and p=0.0001 respectively). The bivariate analysis has showed that the expression of the HLA-B*44 allele was strongly associated with advanced HIV infection (Odd ratio (OR) 0.12 (95% confidence interval (CI) 0.04-0.37), p=0.0001).
Conclusions: Author have described for the first time in Morocco the association of the HLA-B*44 allele with the clinical parameters of HIV infection. These results expand the knowledge of the distribution and effect of this allele in the Moroccan population.
Zhu BF, Yang G, Shen CM, Qin HX, Liu SZ, Deng YJ. Distribution of HLA-A and -B alleles and haplotypes in the Yi ethnic minority of Yunnan, China: relationship to other populations. J Zhejiang Univ-Sci B. 2010 Feb;11(2):127-35.
Ozbek P. Dynamic characterization of HLA-B* 44 alleles: a comparative molecular dynamics simulation study. Computational Biol Chem. 2016;62:12-6.
SGE Marsh, ED Albert, WF Bodmer, RE Bontrop, B Dupont, HA Erlich, et al. Nomenclature for factors of the HLA system. Tissue Antigens. 2010;75:291-455.
Ostermeir K, Springer S, Zacharias M. Coupling between side chain interactions and binding pocket flexibility in HLA-B* 44: 02 molecules investigated by molecular dynamics simulations. Molecular Immunol. 2015;63(2):312-9.
Silva EM, Acosta AX, Santos EJ, Netto EM, Lemaire DC, Oliveira AS, et al. HLA-Bw4-B* 57 and Cw* 18 alleles are associated with plasma viral load modulation in HIV-1 infected individuals in Salvador, Brazil. Braz J Inf Dis. 2010;14(5):468-75.
Chaudhari DV, Chavan VR, Ahir SP, Kerkar SC, Mehta PR, Mania-Pramanik J. Human leukocyte antigen B distribution in HIV discordant cohort from India. Immunol Letters. 2013;156(1-2):1-6.
Gao X, Nelson GW, Karacki P, Martin MP, Phair J, Kaslow R, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. New Eng J Med. 2001;344(22):1668-75.
Hendel H, Caillat-Zucman S, Lebuanec H, Carrington M, O’Brien S, Andrieu JM, et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol. 1999;162(11):6942-6.
O'Brien SJ, Gao X, Carrington M. HLA and AIDS: a cautionary tale. Trends Mol Med. 2001;7(9):379-81.
Tang J, Cormier E, Gilmour J, Price MA, Prentice HA, Song W, et al. Human leukocyte antigen variants B* 44 and B* 57 are consistently favourable during two distinct phases of primary HIV-1 infection in sub-Saharan Africans with several viral subtypes. J Virol. 2011;85(17):8894-902.
Zhang X, Huang X, Xia W, Li W, Zhang T, Wu H, et al. HLA-B* 44 is associated with a lower viral set point and slow CD4 decline in a cohort of Chinese homosexual men acutely infected with HIV-1. Clin Vaccine Immunol. 2013;20(7):1048-54.
Imanishi T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. HLA. 1991. 1992;1:1065-220.
Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proceedings National Acad Sci. 2001;98(9):5140-5.
Herman J, Van Der Bruggen P, Luescher IF, Mandruzzato S, Romero P, Thonnard J, et al. A peptide encoded by the human MAGE3 gene and presented by HLA-1344 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 1996;43(6):377-83.
Biasin M, De Luca M, Gnudi F, Clerici M. The genetic basis of resistance to HIV infection and disease progression. Expert Rev Clin Immunol. 2013;9(4):319-34.
Leslie A, Matthews PC, Listgarten J, Carlson JM, Kadie C, Ndung'u T, et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol. 2010;84(19):9879-88.
Brick C, Atouf O, Bouayad A, Essakalli M. Moroccan study of HLA (-A,-B,-C,-DR,-DQ) polymorphism in 647 unrelated controls: Updating data. Mol Cellular Probes. 2015;29(4):197-207.
Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2010;39(1):D913-9.
Pédron B, Yakouben K, Guérin V, Borsali E, Auvrignon A, Landman J, et al. HLA alleles and haplotypes in French North African immigrants. Human Immunol. 2006;67(7):540-50.
Mahfoudh N, Ayadi I, Kamoun A, Ammar R, Mallek B, Maalej L, et al. Analysis of HLA-A,-B,-C,-DR,-DQ polymorphisms in the South Tunisian population and a comparison with other populations. Ann Human Biol. 2013;40(1):41-7.
Fabio G, Scorza R, Lazzarin A, Marchini M, Zarantonello M, D'arminio A, et al. HLA‐associated susceptibility to HIV‐1 infection. Clin Exp Immunol. 1992;87(1):20-3.